The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus has been an exceptionally successful pathogen, which is still relevant in modern age-medicine due to its adaptability and tenacity. This bacterium may be a causative agent in a plethora of infections, owing to its abundance (in the environment and in the normal flora) and the variety of virulence factors that it possesses. Methicillin-resistant S. aureus (MRSA) strains—first described in 1961—are characterized by an altered penicillin-binding protein (PBP2a/c) and resistance to all penicillins, cephalosporins, and carbapenems, which makes the β-lactam armamentarium clinically ineffective. The acquisition of additional resistance determinants further complicates their eradication; therefore, MRSA can be considered as the first representative of multidrug-resistant bacteria. Based on 230 references, the aim of this review is to recap the history, the emergence, and clinical features of various MRSA infections (hospital-, community-, and livestock-associated), and to summarize the current advances regarding MRSA screening, typing, and therapeutic options (including lipoglycopeptides, oxazolidinones, anti-MRSA cephalosporins, novel pleuromutilin-, tetracycline- and quinolone-derivatives, daptomycin, fusidic acid, in addition to drug candidates in the development phase), both for an audience of clinical microbiologists and infectious disease specialists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192 · cited 2×
“Staphylococci are non-spore forming bacteria, nevertheless they are very common in nature and they can survive in a variety of harsh environments outside of the body, in addition to being resistant to many disinfecting agents [1,2,4,5].”
BackgroundBad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066 · cited 1×
“Brilacidin is a defensin mimetic (defensins are antimicrobial peptides in vertebrates, which are predominantly found in neutrophil granulocytes; they have important roles in innate immunity [208]), which has broad-spectrum antibacterial activity [151,192,209].”
BackgroundMethicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972 · cited 9×
“In contrast, the CA-MRSA strains are associated with smaller genetic elements (carrying the mecA/C gene), which is thought to be influencing their mobility, belonging to the IV, V, or VII allotypes [57,61,85,102].”
BackgroundMethodInfluentialCosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Whole genome sequencing of meticillin-resistant Staphylococcus aureus
Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, I., Cui, L., Oguchi, A., Aoki, K.-I., Nagai, Y., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04403-2 · Cited by 1,961
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., & Spratt, B. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122108599 · Cited by 1,588
Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
Redgrave, L. S., Sutton, S. B., Webber, M. A., & Piddock, L. J. V. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.007 · Cited by 1,008
Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology
Croxatto, A., Prod'hom, G., & Greub, G. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00298.x · Cited by 997
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
What is antimicrobial stewardship?
Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.026 · Cited by 870
Azam, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29020 · Cited by 870
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847
The biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
King, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., & Blumberg, H. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00005 · Cited by 776 · cited 2×
“In contrast, the CA-MRSA strains are associated with smaller genetic elements (carrying the mecA/C gene), which is thought to be influencing their mobility, belonging to the IV, V, or VII allotypes [57,61,85,102].”
BackgroundThe evolution of Staphylococcus aureus
Deurenberg, R. H., & Stobberingh, E. E. (2008) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2008.07.007 · Cited by 721
Knetsch, M. L. W., & Koole, L. H. (2011) · Polymers · doi:10.3390/polym3010340 · Cited by 715
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., Rossolini, G. M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03703.x · Cited by 683
Penicillin's Discovery and Antibiotic Resistance: Lessons for the Future?
Lobanovska, M., & Pilla, G. (2017) · PubMed Central · Cited by 631
Hassoun, A., Linden, P. K., & Friedman, B. (2017) · Critical Care · doi:10.1186/s13054-017-1801-3 · Cited by 604
The Discovery of Penicillin—New Insights After More Than 75 Years of Clinical Use
Gaynes, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2305.161556 · Cited by 597
Bacteriophage therapy: a potential solution for the antibiotic resistance crisis
Golkar, Z., Bagasra, O., & Pace, D. G. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3573 · Cited by 593
Stefani, S., Chung, D. R., Lindsay, J. A., Friedrich, A. W., Kearns, A. M., Westh, H., & MacKenzie, F. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.030 · Cited by 590 · cited 6×
“In contrast, the CA-MRSA strains are associated with smaller genetic elements (carrying the mecA/C gene), which is thought to be influencing their mobility, belonging to the IV, V, or VII allotypes [57,61,85,102].”
BackgroundInfluentialMultidrug-Resistant Bacteria in the Community
van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Lawson, P. A., Citron, D. M., Tyrrell, K. L., & Finegold, S. M. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.06.008 · Cited by 564
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Qiu, Z., Yu, Y., Chen, Z., Jin, M., Yang, D., Zhao, Z., Wang, J., Shen, Z., Wang, X., Qian, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107254109 · Cited by 538
Vancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
Koreen, L., Ramaswamy, S. V., Graviss, E. A., Naidich, S., Musser, J. M., & Kreiswirth, B. N. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.792-799.2004 · Cited by 484
The emergence of mecC methicillin-resistant Staphylococcus aureus
Paterson, G. K., Harrison, E. M., & Holmes, M. A. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.11.003 · Cited by 470
Graffunder, E. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf009 · Cited by 411
Shore, A. C., Deasy, E. C., Slickers, P., Brennan, G., O'Connell, B., Monecke, S., Ehricht, R., & Coleman, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00187-11 · Cited by 383
Rupp, M. E., & Fey, P. D. (2003) · Drugs · doi:10.2165/00003495-200363040-00002 · Cited by 379
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Long, K. S., & Vester, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 375
Pathogenesis of Staphylococcus aureus Abscesses
Kobayashi, S. D., Malachowa, N., & DeLeo, F. R. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.11.030 · Cited by 351
Otto, M. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01832.x · Cited by 342
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
Eady, E. A., & Cove, J. H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200304000-00007 · Cited by 329 · cited 2×
“In the 1980–1990s, CA- and HA-MRSA strains could be safely distinguished by phenotypic characteristics: the HA-MRSA strains were more frequently MDR strains (resistant to antibiotics other than β-lactams), while the CA-MRSA strains were predominantly susceptible to non-β-lactams [31].”
BackgroundKahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
Liu, C., & Chambers, H. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3040-3045.2003 · Cited by 321
Livestock-Associated MRSA: The Impact on Humans
Cuny, C., Wieler, L., & Witte, W. (2015) · Antibiotics · doi:10.3390/antibiotics4040521 · Cited by 312
Weinstein, R. A., & Fridkin, S. K. (2001) · Clinical Infectious Diseases · doi:10.1086/317542 · Cited by 304
Something old, something new: revisiting natural products in antibiotic drug discovery
Wright, G. D. (2014) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0063 · Cited by 283
Staphylococcus aureus in veterinary medicine
Peton, V., & Le Loir, Y. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.08.011 · Cited by 280
Mechanism of action of oritavancin and related glycopeptide antibiotics
Allen, N. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00144-4 · Cited by 276
The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria
Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 276
The use of vancomycin with its therapeutic and adverse effects: a review.
Bruniera, F. R., Ferreira, F. M., Saviolli, L. R. M., Bacci, M. R., Feder, D., Pedreira, M. D. L. G., Peterlini, M. A. S., Azzalis, L. A., Junqueira, V. B. C., & Fonseca, F. L. A. (2015) · PubMed · Cited by 275
The Concept of an Ideal Antibiotic: Implications for Drug Design
Gajdács, M. (2019) · Molecules · doi:10.3390/molecules24050892 · Cited by 271
Self-citationTigecycline: what is it, and where should it be used?
Livermore, D. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki291 · Cited by 261
Staphylococcus aureus: Determinants of human carriage
Sollid, J. U. E., Furberg, A. S., Hanssen, A. M., & Johannessen, M. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.03.020 · Cited by 257
Carbapenemase-Producing Enterobacteriaceae
Paterson, D., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257
Proctor, R. A., Kriegeskorte, A., Kahl, B. C., Becker, K., Löffler, B., & Peters, G. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00099 · Cited by 237
Moellering, R. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr437 · Cited by 236 · cited 1×
“The spread of CA-MRSA has been reported from basically every region on the planet and this has become the principle type of MRSA infection in the past 10–20 year, owing to successful clones [57,58].”
BackgroundSutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Mechanisms of drug resistance: daptomycin resistance
Tran, T. T., Munita, J. M., & Arias, C. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12948 · Cited by 234
Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study
Daneman, N., Lu, H., & Redelmeier, D. A. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-010077 · Cited by 225
Solomkin, J. S., Gardovskis, J., Lawrence, K., Montravers, P., Sway, A., Evans, D., & Tsai, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1029 · Cited by 222
Pleuromutilins: Potent Drugs for Resistant Bugs—Mode of Action and Resistance
Paukner, S., & Riedl, R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027110 · Cited by 215
Wolk, D. M., Struelens, M. J., Pancholi, P., Davis, T., Della-Latta, P., Fuller, D., Picton, E., Dickenson, R., Denis, O., Johnson, D., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01884-08 · Cited by 214
Appropriate prescribing of oral beta-lactam antibiotics.
Holten, K. B., & Onusko, E. (2000) · PubMed · Cited by 208
Staphylococcus aureus CcpA Affects Virulence Determinant Production and Antibiotic Resistance
Seidl, K., Stucki, M., Ruegg, M., Goerke, C., Wolz, C., Harris, L., Berger-Bächi, B., & Bischoff, M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1183-1194.2006 · Cited by 207
The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
Lee, B. Y., Singh, A., David, M. Z., Bartsch, S. M., Slayton, R. B., Huang, S. S., Zimmer, S. M., Potter, M. A., Macal, C. M., Lauderdale, D. S., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03914.x · Cited by 207
What is an “ideal” antibiotic? Discovery challenges and path forward
Singh, S. B., Young, K., & Silver, L. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.003 · Cited by 201
Lahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03057-14 · Cited by 197
Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA
Poovelikunnel, T., Gethin, G., & Humphreys, H. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv169 · Cited by 192
Spengler, G., Kincses, A., Gajdács, M., & Amaral, L. (2017) · Molecules · doi:10.3390/molecules22030468 · Cited by 189
Self-citationKaur, D., & Chate, S. (2015) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.157245 · Cited by 188
New natural products as new leads for antibacterial drug discovery
Brown, D. G., Lister, T., & May-Dracka, T. L. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.059 · Cited by 186
Comparative Mechanistic Studies of Brilacidin, Daptomycin, and the Antimicrobial Peptide LL16
Mensa, B., Howell, G. L., Scott, R., & DeGrado, W. F. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02955-14 · Cited by 185
Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt072 · Cited by 177
Love, M., Bhandari, D., Dobson, R., & Billington, C. (2018) · Antibiotics · doi:10.3390/antibiotics7010017 · Cited by 173
Microbial Efflux Pump Inhibition: Tactics and Strategies
Tegos, G. P., Haynes, M. K., Strouse, J. J., Khan, M. M. T., Bologa, C., Oprea, T. I., & Sklar, L. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795703726 · Cited by 171
Amaral, L., Martins, A., Spengler, G., & Molnar, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00168 · Cited by 170
Handzlik, J., Matys, A., & Kieć-Kononowicz, K. (2013) · Antibiotics · doi:10.3390/antibiotics2010028 · Cited by 170
Gajdács, M., Spengler, G., & Urbán, E. (2017) · Antibiotics · doi:10.3390/antibiotics6040025 · Cited by 169
Self-citationBenagli, C., Rossi, V., Dolina, M., Tonolla, M., & Petrini, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016424 · Cited by 168
Staphylococci and their Classification
Shaw, C., Stitt, J. M., & Cowan, S. T. (1951) · Journal of General Microbiology · doi:10.1099/00221287-5-5-1010 · Cited by 164
Small colony variants of Staphylococcus aureus — review
Melter, O., & Radojevič, B. (2010) · Folia Microbiologica · doi:10.1007/s12223-010-0089-3 · Cited by 163
Dulon, M., Peters, C., Schablon, A., & Nienhaus, A. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-363 · Cited by 163
Igniting the Fire: Staphylococcus aureus Virulence Factors in the Pathogenesis of Sepsis
Powers, M. E., & Wardenburg, J. B. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003871 · Cited by 162
Spellberg, B. J. (2014) · Critical Care · doi:10.1186/cc13948 · Cited by 162
Bergler, H., Fuchsbichler, S., Högenauer, G., & Turnowsky, F. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0689r.x · Cited by 159
Expression of Virulence Factors by Staphylococcus aureus Grown in Serum
Oogai, Y., Matsuo, M., Hashimoto, M., Kato, F., Sugai, M., & Komatsuzawa, H. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05316-11 · Cited by 155
Dukić, V., Lauderdale, D. S., Wilder, J. R., Daum, R. S., & David, M. Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052722 · Cited by 152
Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany
Cuny, C., Köck, R., & Witte, W. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.010 · Cited by 150
Lacey, K., Geoghegan, J., & McLoughlin, R. (2016) · Pathogens · doi:10.3390/pathogens5010022 · Cited by 146
Helix Stability Confers Salt Resistance upon Helical Antimicrobial Peptides
Park, I. Y., Cho, J. H., Kim, K. S., Kim, Y.-B., Kim, M. S., & Kim, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311418200 · Cited by 145
Novel SCC mec type XIII (9A) identified in an ST152 methicillin-resistant Staphylococcus aureus
Baig, S., Johannesen, T. B., Overballe‐Petersen, S., Larsen, J., Larsen, A. R., & Stegger, M. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.03.013 · Cited by 145
Haque, S., Ahmad, F., Dar, S. A., Jawed, A., Mandal, R. K., Wahid, M., Lohani, M., Khan, S. A., Singh, V., & Akhter, N. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.046 · Cited by 143
Bhatta, D. R., Cavaco, L. M., Nath, G., Kumar, K., Gaur, A., Gokhale, S., & Bhatta, D. R. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1531-1 · Cited by 136
Florescu, I., Beuran, M., Dimov, R., Razbadauskas, A., Bochan, M. R., Fichev, G., Dukart, G., Babinchak, T., Cooper, C. A., Ellis‐Grosse, E. J., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn250 · Cited by 134
Current and future prospects for CRISPR‐based tools in bacteria
Luo, M. L., Leenay, R. T., & Beisel, C. L. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25851 · Cited by 129
Staphylococcal Cassette Chromosome mec (SCCmec) Analysis of MRSA
Ito, T., Kuwahara‐Arai, K., Katayama, Y., Uehara, Y., Han, X., Kondo, Y., & Hiramatsu, K. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_8 · Cited by 129
Morell, E. A., & Balkin, D. M. (2010) · PubMed Central · Cited by 127
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Villano, S. A., Steenbergen, J. N., & Loh, E. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0100 · Cited by 122
Linezolid Resistance in Staphylococci
Stefani, S., Bongiorno, D., Mongelli, G., & Campanile, F. (2010) · Pharmaceuticals · doi:10.3390/ph3071988 · Cited by 119
Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants
Ericson, J. E., Popoola, V. O., Smith, P. B., Benjamin, D. K., Fowler, V. G., Benjamin, D. K., Clark, R. H., & Milstone, A. M. (2015) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2015.2380 · Cited by 117
Antibacterial effect of zinc oxide nanoparticles combined with ultrasound
Seil, J. T., & Webster, T. J. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/49/495101 · Cited by 115
The Role of Antibiotic Stewardship in Promoting Appropriate Antibiotic Use
Ha, D. R., Haste, N. M., & Gluckstein, D. P. (2017) · American Journal of Lifestyle Medicine · doi:10.1177/1559827617700824 · Cited by 115
Mupirocin: a topical antibiotic with a unique structure and mechanism of action.
PARENTI, M. A., Hatfield, S. M., & Leyden, J. J. (1987) · PubMed · Cited by 109
Ballhausen, B., Kriegeskorte, A., Schleimer, N., Peters, G., & Becker, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02731-13 · Cited by 108
Evolutionary Origin of the Staphylococcal Cassette Chromosome mec (SCC mec )
Rolo, J., Worning, P., Nielsen, J. B., Bowden, R., Bouchami, O., Damborg, P., Guardabassi, L., Perreten, V., Tomasz, A., Westh, H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02302-16 · Cited by 106
Staphylococcal Cassette Chromosome mec (SCCmec) Analysis of MRSA
Ito, T., Kuwahara, K., & Hiramatsu, K. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-468-1_7 · Cited by 104
Schiebel, J., Chang, A. T., Lu, H., Baxter, M. V., Tonge, P. J., & Kisker, C. (2012) · Structure · doi:10.1016/j.str.2012.03.013 · Cited by 102
Agents for the Decolonization of Methicillin‐Resistant Staphylococcus aureus
McConeghy, K. W., Mikolich, D. J., & LaPlante, K. L. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.3.263 · Cited by 102
Livestock-Associated MRSA and Its Current Evolution
Butaye, P., Argudín, M. Á., & Smith, T. C. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0031-9 · Cited by 100
Fritsche, T. R., Sader, H. S., & Jones, R. N. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.02.008 · Cited by 99
McCurdy, S. P., Lawrence, L. E., Quintas, M., Woosley, L. N., Flamm, R. K., Tseng, C., & Cammarata, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00772-17 · Cited by 95
Outpatient Parenteral Antimicrobial Therapy
Laupland, K. B., & Valiquette, L. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/205910 · Cited by 94
Manukumar, H. M. G., & Umesha, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-11597-z · Cited by 94
Staphylococcus aureus Virulence Expression Is Impaired by Lactococcus lactis in Mixed Cultures
Even, S., Charlier, C., Nouaille, S., Zakour, N. L. B., Cretenet, M., Cousin, F., Gautier, M., Cocaign‐Bousquet, M., Loubière, P., & Loir, Y. L. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.02388-08 · Cited by 87
Staphylococcal Toxic Shock Syndrome: Mechanisms and Management
Silversides, J. A., Lappin, E., & Ferguson, A. J. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0119-y · Cited by 86
New and improved? A review of novel antibiotics for Gram-positive bacteria
Abbas, M., Paul, M., & Huttner, A. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.010 · Cited by 86
Paukner, S., Sader, H. S., Ivezic‐Schoenfeld, Z., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00358-13 · Cited by 84
Duplessis, C. A., & Crum‐Cianflone, N. F. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s1637 · Cited by 83
Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications
Scott, R. W., & Tew, G. N. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160713130452 · Cited by 81
Suppression of Staphylococcus aureus virulence by a small-molecule compound
Gao, P., Ho, P., Yan, B., Sze, K. H., DAVIES, J. E., & Kao, R. Y. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720520115 · Cited by 80
Tong, S. Y. C., Nelson, J., Paterson, D. L., Fowler, V. G., Howden, B. P., Cheng, A. C., Chatfield, M. D., Lipman, J., van Hal, S., O'Sullivan, M. V. N., et al. (2016) · Trials · doi:10.1186/s13063-016-1295-3 · Cited by 77
Allen, N. E., LeTourneau, D. L., & Hobbs, J. N. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.66 · Cited by 76
spa Typing for Epidemiological Surveillance of Staphylococcus aureus
Hallin, M., Friedrich, A. W., & Struelens, M. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-999-4_15 · Cited by 74
Lai, C., Liao, C., Pai, M., Chu, F., Hsu, S.-P., Chen, H., Yang, J., Chiu, Y., Peng, Y., Chang, S., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06270710 · Cited by 74
PFGE diversity within the methicillin-resistant Staphylococcus aureus clonal lineage ST398
Bosch, T., de Neeling, A. J., Schouls, L. M., van der Zwaluw, K., Kluytmans, J. A. J. W., Grundmann, H., & Huijsdens, X. W. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-40 · Cited by 74
Gijón, M., Bellusci, M., Petraitienė, B., Noguera‐Julián, A., Žilinskaitė, V., Moreno, P. S., Saavedra‐Lozano, J., Glikman, D., Daskalaki, M., Kaiser‐Labusch, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.004 · Cited by 73
Cruz, J., Flórez, J., Torres, R. G., Urquiza, M., Gutiérrez, J. A., Guzmán, F., & Ortiz, C. C. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa5f63 · Cited by 71
Wolk, D. M., Marx, J. L., Dominguez, L., Driscoll, D. G., & Schifman, R. B. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00601-09 · Cited by 70
Yanagihara, K., Tashiro, M., Fukuda, Y., Ohno, H., Higashiyama, Y., Miyazaki, Y., Hirakata, Y., Tomono, K., Mizuta, Y., Tsukamoto, K., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki416 · Cited by 69
Sharma, M., Nuñéz-García, J., Kearns, A., Doumith, M., Butaye, P., Argudín, M. Á., Lahuerta‐Marin, A., Pichon, B., AbuOun, M., Rogers, J., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01741 · Cited by 69
Lalani, T., Boucher, H. W., Cosgrove, S. E., Fowler, V. G., Kanafani, Z. A., Vigliani, G. A., Campion, M., Abrutyn, E., Levine, D. P., Price, C. S., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm437 · Cited by 67
Defensin-based anti-infective strategies
Wilmes, M., & Sahl, H. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.08.007 · Cited by 66
Plasmid-encoded trimethoprim resistance in staphylococci
Archer, G. L., Coughter, J. P., & Johnston, J. L. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.5.733 · Cited by 66
Stevens, A. M., Hennessy, T., Baggett, H. C., Bruden, D. J. T., Parks, D., & Klejka, J. A. (2010) · Emerging infectious diseases · doi:10.3201/eid1605.091851 · Cited by 65
Clostridium difficile infection: a review of the literature
Khan, F. Y., & Elzouki, A.-N. Y. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60197-8 · Cited by 64
Panton-Valentine Leukocidin–producing Staphylococcus aureus
Adler, A., Temper, V., Block, C. S., Abramson, N., & Moses, A. E. (2006) · Emerging infectious diseases · doi:10.3201/eid1211.060726 · Cited by 63
Delafloxacin: design, development and potential place in therapy
Candel, F., & Peñuelas, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s106071 · Cited by 63
Cunningham, S. A., Chia, N., Jeraldo, P., Quest, D. J., Johnson, J. A., Boxrud, D. J., Taylor, A., Chen, J., Jenkins, G. D., Drucker, T., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00029-17 · Cited by 63
Ruppé, É., Burdet, C., Grall, N., LASTOURS, V. D., Lescure, F.-X., Andremont, A., & Armand-Lefèvre, L. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.09.017 · Cited by 63
Beyond Vancomycin: The Tail of the Lipoglycopeptides
Klinker, K. P., & Borgert, S. J. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.11.007 · Cited by 59
Dorado-García, A., Bos, M. E. H., Graveland, H., van Cleef, B. A. G. L., Verstappen, K. M. H. W., Kluytmans, J. A. J. W., Wagenaar, J. A., & Heederik, D. J. J. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003272 · Cited by 55
Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus
Hibbitts, A., & O’Leary, C. (2018) · Materials · doi:10.3390/ma11020321 · Cited by 54
Ceftobiprole: An Extended-Spectrum Anti–Methicillin-Resistant Staphylococcus aureus Cephalosporin
Anderson, S. D., & Gums, J. G. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l016 · Cited by 50
The role of tigecycline in the treatment of infections in light of the new black box warning
Dixit, D., Madduri, R. P., & Sharma, R. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.894882 · Cited by 49
Staphylococcus aureus protein A induced inflammatory response in human corneal epithelial cells
Kumar, A., Tassopoulos, A. M., Li, Q., & Yu, F. X. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.072 · Cited by 46
Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections
Falagas, M. E., & Vardakas, K. Z. (2008) · Drug Safety · doi:10.2165/00002018-200831090-00004 · Cited by 46
Protein therapeutics: promises and challenges for the 21st century
Weng, Z., & DeLisi, C. (2002) · Trends in biotechnology · doi:10.1016/s0167-7799(01)01846-7 · Cited by 44
Gomes-Fernandes, M., Laabei, M., Pagan, N., Hidalgo, J., Molinos, S., Villar-Hernández, R., Domínguez‐Villanueva, D., Jenkins, A. T. A., Lacoma, A., & Prat, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175552 · Cited by 44
Clowry, J., Irvine, A. D., & McLoughlin, R. M. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.038 · Cited by 44
Cadena, J., Nair, S., Henao‐Martínez, A. F., Jorgensen, J. H., PATTERSON, J. E., & Sreeramoju, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00706-11 · Cited by 43
Moore, C. L., Lü, M., Cheema, F., Osaki-Kiyan, P., Perri, M. B., Donabedian, S. M., Haque, N. Z., & Zervos, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-11 · Cited by 43
Flamm, R. K., Rhomberg, P. R., Huband, M. D., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00941-16 · Cited by 43
Jacobs, M. R. (2007) · Future Microbiology · doi:10.2217/17460913.2.6.591 · Cited by 41
Current and novel antibiotics against resistant Gram-positive bacteria
Pérez, F., Salata, R. A., & Bonomo, R. A. (2008) · Infection and Drug Resistance · doi:10.2147/idr.s3545 · Cited by 40
Omadacycline: A New Tetracycline Antibiotic
Dougherty, J. A., Sucher, A. J., Chahine, E. B., & Shihadeh, K. C. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018818094 · Cited by 37
Methicillin-Resistant Staphylococcus aureus Harboring mecC in Livestock in Spain
Ariza-Miguel, J., Hernández, M., Fernández-Natal, I., & Rodrı́guez-Làzaro, D. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01815-14 · Cited by 36
Bhambri, S., & Kim, G. (2009) · PubMed Central · Cited by 35
Pharmacogenomics of Antimicrobial Agents
Aung, A. K., Haas, D. W., Hulgan, T., & Phillips, E. J. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.147 · Cited by 35
Pronounced activity of aromatic selenocyanates against multidrug resistant ESKAPE bacteria
Nasim, M. J., Witek, K., Kincses, A., Abdin, A. Y., Żesławska, E., Marć, M. A., Gajdács, M., Spengler, G., Nitek, W., Latacz, G., et al. (2019) · New Journal of Chemistry · doi:10.1039/c9nj00563c · Cited by 34
Self-citationFelicetti, T., Cannalire, R., Burali, M. S., Massari, S., Manfroni, G., Barreca, M. L., Tabarrini, O., Schindler, B. D., Sabatini, S., Kaatz, G. W., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700286 · Cited by 32
Ménétrey, A., Janin, A., Pullman, J. R., Overcash, J. S., Haouala, A., Leylavergne, F., Turbe, L., Wittke, F., & Nicolas‐Métral, V. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01669-18 · Cited by 30
Biedenbach, D. J., Arhin, F. F., Moeck, G., Lynch, T. F., & Sahm, D. F. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.014 · Cited by 26
Next-generation sequencing to monitor the spread of antimicrobial resistance
Otto, M. J. (2017) · Genome Medicine · doi:10.1186/s13073-017-0461-x · Cited by 26
A fizikai aktivitás, mint egészségbefektetés
Pfau, C. S., Pető, K., & Bába, É. B. (2019) · Egészségfejlesztés · doi:10.24365/ef.v60i1.354 · Cited by 26
Urbán, E. Z., & Stone, G. G. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.023 · Cited by 23
hVISA/VISA: diagnostic and therapeutic problems
Szabó, J. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.7.1.1 · Cited by 20
Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity
Ahn, M., Jacob, B., Gunasekaran, P., Murugan, R. N., Ryu, E. K., Lee, G.-H., Hyun, J., Cheong, C., Kim, N., Shin, S. Y., et al. (2014) · Amino Acids · doi:10.1007/s00726-014-1778-z · Cited by 18
Antistaphylococcal Vaccines and Immunoglobulins
Deresinski, S. C. (2006) · Drugs · doi:10.2165/00003495-200666140-00002 · Cited by 18
Bérenger, R., Bourdon, N., Auzou, M., Leclercq, R., & Cattoir, V. (2011) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2010.12.013 · Cited by 15
MRSA diversity and the emergence of LA-MRSA in a large teaching hospital in Slovenia
Kevorkijan, B. K., Petrovič, Ž., Kocuvan, A., & Rupnik, M. (2018) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/030.65.2018.052 · Cited by 13
(2017) · PubMed Central
Cited by
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace
Chinemerem Nwobodo, D., Ugwu, M. C., Oliseloke Anie, C., Al‐Ouqaili, M. T. S., Chinedu Ikem, J., Victor Chigozie, U., & Saki, M. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24655 · Cited by 985
Algammal, A. M., Hetta, H. F., Elkelish, A., Alkhalifah, D. H. H., Hozzein, W. N., Batiha, G. E.-S., El Nahhas, N., & Mabrok, M. A. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s272733 · Cited by 403
Propolis as a novel antibacterial agent
Almuhayawi, M. S. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.09.016 · Cited by 279
El-Saadony, M. T., Saad, A. M., Mohammed, D. M., Korma, S. A., Alshahrani, M. Y., Ahmed, A. E., Ibrahim, E. H., Salem, H. M., Alkafaas, S. S., Saif, A. M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1491777 · Cited by 197
“The swift global proliferation of methicillin-and vancomycin-resistant S. aureus strains is rendering containment increasingly unfeasible, potentially reverting us to the pre-antibiotic era (94).”
Influential
Metadata
- Authors
- Gajdács, M.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2019-05-02
- Volume
- 8
- Issue
- 2
- Pages
- 52
- ISSN
- 2079-6382 (ISSN-L)
- OpenAlex
- W2943209288
- Cited by
- 318
- References
- 181
- FWCI
- 28.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.